author-photo

Supriya Goud

Tata Memorial Hospital

31

Papers

187

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

P88.03 Asymptomatic COVID-19 in a ROS1 positive Non Small Cell Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P09.48 Experience and Outcome of COVID-19-Positive Lung Cancer Patients from a Eastern Indian Hospital

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings.

2021 Ecancermedicalscience
Show All
- Source
- Cite
- Save
Citations (0)
A randomized clinical trial evaluating the efficacy and safety of the addition of oral metronomic chemotherapy after completion of standard chemoradiation versus observation in patients with locally advanced esophageal and gastroesophageal junction squamous cell carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of COVID-19 on oncology clinical trials: A “novel“ challenge

2020
Show All
- Source
- Cite
- Save
Citations (0)
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer

2019 EClinicalMedicine
Show All
- Source
- Cite
- Save
Citations (2)
Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (21)
Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer

2019 Oncotarget
Show All
- Source
- Cite
- Save
Citations (0)
Quality of life analysis of Pemetrexed versus Erlotinib maintenance in EGFR mutation negative advanced non small cell lung cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
LBA10A randomized investigator initiated phase III study comparing low dose gemcitabine to standard dose gemcitabine with platinum in advanced squamous non driver mutated non-small cell lung cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)